These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1793013)

  • 1. Methoxyalkyl thiazoles: a novel series of potent, orally active and enantioselective inhibitors of 5-lipoxygenase.
    McMillan RM; Bird TG; Crawley GC; Edwards MP; Girodeau JM; Kingston JF; Foster SJ
    Agents Actions; 1991 Sep; 34(1-2):110-2. PubMed ID: 1793013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (Methoxyalkyl)thiazoles: a new series of potent, selective, and orally active 5-lipoxygenase inhibitors displaying high enantioselectivity.
    Bird ; Bruneau P; Crawley GC; Edwards MP; Foster SJ; Girodeau JM; Kingston JF; McMillan RM
    J Med Chem; 1991 Jul; 34(7):2176-86. PubMed ID: 1648621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methoxytetrahydropyrans. A new series of selective and orally potent 5-lipoxygenase inhibitors.
    Crawley GC; Dowell RI; Edwards PN; Foster SJ; McMillan RM; Walker ER; Waterson D; Bird TG; Bruneau P; Giroaeau JM
    J Med Chem; 1992 Jul; 35(14):2600-9. PubMed ID: 1321908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naphthalenic lignan lactones as selective, nonredox 5-lipoxygenase inhibitors. Synthesis and biological activity of (methoxyalkyl)thiazole and methoxytetrahydropyran hybrids.
    Ducharme Y; Brideau C; Dubé D; Chan CC; Falgueyret JP; Gillard JW; Guay J; Hutchinson JH; McFarlane CS; Riendeau D
    J Med Chem; 1994 Feb; 37(4):512-8. PubMed ID: 8120869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Criteria for the identification of non-redox inhibitors of 5-lipoxygenase.
    Falgueyret JP; Hutchinson JH; Riendeau D
    Biochem Pharmacol; 1993 Feb; 45(4):978-81. PubMed ID: 8452572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational analysis of 5-lipoxygenase inhibitors: role of the substituents in chiral recognition and on the active conformations of the (methoxyalkyl)thiazole and methoxytetrahydropyran series.
    Lambert-van der Brempt C; Bruneau P; Lamorlette MA; Foster SJ
    J Med Chem; 1994 Jan; 37(1):113-24. PubMed ID: 8289184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
    McMillan RM; Spruce KE; Crawley GC; Walker ER; Foster SJ
    Br J Pharmacol; 1992 Dec; 107(4):1042-7. PubMed ID: 1334748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective chiral inhibitors of 5-lipoxygenase with anti-inflammatory activity.
    McMillan RM; Girodeau JM; Foster SJ
    Br J Pharmacol; 1990 Nov; 101(3):501-3. PubMed ID: 1963796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-substituted indazolinones: orally active and selective 5-lipoxygenase inhibitors with anti-inflammatory activity.
    Foster SJ; Bruneau P; Walker ER; McMillan RM
    Br J Pharmacol; 1990 Jan; 99(1):113-8. PubMed ID: 2110012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the new 5-lipoxygenase inhibitor E6080 on leukotriene release in vitro.
    Sakuma Y; Katayama S; Tsunoda H; Abe S; Yamatsu I; Katayama K
    Int Arch Allergy Immunol; 1992; 97(4):267-73. PubMed ID: 1375926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiopyrano[2,3,4-cd]indoles as 5-lipoxygenase inhibitors: synthesis, biological profile, and resolution of 2-[2-[1-(4-chlorobenzyl)-4-methyl-6-[(5-phenylpyridin-2-yl)methoxy]-4,5 -dihydro-1H-thiopyrano[2,3,4-cd]indol-2-yl]ethoxy]butanoic acid.
    Hutchinson JH; Riendeau D; Brideau C; Chan C; Falgueyret JP; Guay J; Jones TR; Lépine C; Macdonald D; McFarlane CS
    J Med Chem; 1994 Apr; 37(8):1153-64. PubMed ID: 8164257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azole phenoxy hydroxyureas as selective and orally active inhibitors of 5-lipoxygenase.
    Malamas MS; Carlson RP; Grimes D; Howell R; Glaser K; Gunawan I; Nelson JA; Kanzelberger M; Shah U; Hartman DA
    J Med Chem; 1996 Jan; 39(1):237-45. PubMed ID: 8568813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzoxazolamines and benzothiazolamines: potent, enantioselective inhibitors of leukotriene biosynthesis with a novel mechanism of action.
    Lazer ES; Miao CK; Wong HC; Sorcek R; Spero DM; Gilman A; Pal K; Behnke M; Graham AG; Watrous JM
    J Med Chem; 1994 Apr; 37(7):913-23. PubMed ID: 8151618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A class of 5-benzylidene-2-phenylthiazolinones with high potency as direct 5-lipoxygenase inhibitors.
    Hofmann B; Barzen S; Rödl CB; Kiehl A; Borig J; Zivković A; Stark H; Schneider G; Steinhilber D
    J Med Chem; 2011 Mar; 54(6):1943-7. PubMed ID: 21341744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and identification of novel substituted 2-amino thiazole analogues as potential anti-inflammatory agents targeting 5-lipoxygenase.
    Sinha S; Doble M; Manju SL
    Eur J Med Chem; 2018 Oct; 158():34-50. PubMed ID: 30199704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and activity relationships leading to the discovery of ICI D2138, a selective, potent and orally active inhibitor of 5-lipoxygenase.
    Crawley GC; Bird TG; Bruneau P; Dowell RI; Edwards PN; Foster SJ; Girodeau JM; McMillan RM; Walker ER; Waterson D
    J Lipid Mediat; 1993; 6(1-3):249-57. PubMed ID: 8395247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activity.
    Grimes D; Sturm RJ; Marinari LR; Carlson RP; Berkenkopf JW; Musser JH; Kreft AF; Weichman BM
    Eur J Pharmacol; 1993 May; 236(2):217-28. PubMed ID: 8391458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylsulphonyl urenyl chalcone derivatives as dual inhibitors of cyclo-oxygenase-2 and 5-lipoxygenase.
    Araico A; Terencio MC; Alcaraz MJ; Domínguez JN; León C; Ferrándiz ML
    Life Sci; 2006 May; 78(25):2911-8. PubMed ID: 16360707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological cross-reactivity between 5-lipoxygenase-activating protein, 5-lipoxygenase, and leukotriene C4 synthase.
    Gupta N; Nicholson DW; Ford-Hutchinson AW
    Can J Physiol Pharmacol; 1997; 75(10-11):1212-9. PubMed ID: 9431445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.